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Localization and regulation of renal Na/myo-inositol cotransporter in
diabetic rats. We have examined the effect of diabetes on sodium/myo-
inositol cotransporter (SMIT) mRNA levels and myo-inositol content in
the kidney to test the hypothesis that diabetes-induced changes in renal
myo-inositol levels are due to the regulation of SMIT mRNA levels. In
streptozotocin-induced diabetic rats, after 3, 7 and 28 days of diabetes,
SMIT mRNA levels in the whole kidney were increased three- to fivefold,
and remained increased by about twofold after six months of diabetes.
Insulin treatment of diabetic rats normalized blood glucose levels and
prevented the increase in SMIT mRNA levels. Treating diabetic rats with
sorbinil, an aldose reductase inhibitor, corrected the abnormal accumula-
tion of sorbitol but had no effect on the diabetes-induced increase in renal
SMIT mRNA levels. The regional distribution of SMIT mRNA from
normal rats showed a relative abundance in cortex, outer medulla, and
inner medulla of 1.0:3.4:7.0. After seven days of diabetes, the levels of
SMIT mRNA and myo-inositol content were significantly increased only in
the outer medulla. In situ hybridization studies revealed that SMIT mRNA
in the outer medulla was predominately localized to the medullary thick
ascending limbs of Henle's loop and was not localized to any specific cell
in the inner medulla. This distribution pattern was unchanged in diabetic
rats. These studies show that diabetes causes an increase in renal SMIT
mRNA, which is primarily localized to the outer medulla. Accumulation of
myo-inositol by the thick ascending limb of Henle's loop may account for
most of the increase caused by diabetes.
myo-Inositol plays at least two important roles in cell function.
First, it has an integral role in signal transduction by virtue of its
incorporation into phosphoinositides and subsequent release as
secondary messengers upon hormonal activation of a phospho-
inositide specific phospholipase C [1, 2]. Second, myo-inositol is
an important osmolyte, serving to protect cells exposed to hyper-
tonic conditions [31. This protective role is shared with other
osmolytes such as sorbitol, hetaine, and glycerophosphorylcho-
line, but these osmolytes may differ in the mechanisms responsible
for their regulation and in their specific effects.
In most mammalian cells the intracellular concentration of
myo-inositol is many times higher than circulating levels [4, 5].
This condition is regulated and maintained by a Na/myo-inositol
cotransporter (SMIT) that is widely expressed in mammalian cells
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[6, 7]. One of the most potent means to increase the activity of
SMIT and thus myo-inositol accumulation is hypertonicity [8—10].
This increased transport capacity is dependent on increased
transcription of the SMIT gene [9]. Because the renal medulla is
normally hypertonic, several investigators have focused on these
renal cells in particular to understand various aspects of rnyo-
inositol transport and metabolism. One of the most consistent
observations is that myo-inositol is the major osmolyte in the outer
medulla, while the other osmolytes play a quantitatively greater
role in the inner medulla [6, 111.
One of the well described effects of hyperglycemia in some
cultured cells and animal models is depletion of intracellular
myo-inositol [12—15]. This depletion of myo-inositol has been
postulated to play a role in some of the complications of diabetes
[16, 17]. However, there is good evidence that the change in
myo-inositol content in response to hyperglycemia is tissue and
cell specific [18]. Hyperglycemia-induced myo-inositol deficiency
has been associated primarily with sorbitol accumulation by
neural tissue and diabetic neuropathy [14—18]. In contrast, there
has been conflicting data regarding the effects of diabetes on
myo-inositol content of other tissues such as the retina [19, 20].
The effects of hyperglycemia on myo-inositol content of renal cells
appears to be complex. There is conflicting data about the effects
on mesangial cells [18, 21]. However, there consistent evidence
that diabetes increases the myo-inositol content of the outer
medulla while having no effect on the myo-inositol content of the
inner medulla/papilla [11, 18]. Therefore, it appears that rnyo-
inositol metabolism ensuing from hyperglycemia varies in differ-
ent tissues.
Because diabetes is a hypertonic state and because hypertonic-
ity is an important stimulus for myo-inositol uptake and SMIT
gene transcription, we sought to investigate the effects of diabetes
on myo-inositol content and SMIT mRNA levels in the three
regions of the kidney. We also localized SMIT mRNA in normal
and diabetic kidneys by in situ hybridization. The results demon-
strate the importance of the medullary thick ascending limb of
Henle's loop as an important structure in myo-inositol transport
and SMIT mRNA regulation.
Methods
Materials
Chemicals were from Sigma Chemical Co. (St. Louis, MO,
USA) unless otherwise noted. Streptozotocin was from Upjohn
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(Kalamazoo, MI, USA). Ethanol, chloroform, triethanolamine,
and isoamyl alcohol were from Fisher Scientific (Fair Lawn, NJ,
USA). Phenol was from Bethesda Research Laboratories (Gaith-
ersburg, MD, USA). Sorbinil was a gift from Pfizer (Groton, CT,
USA). Ethidium bromide and proteinase K were from Boehr-
inger-Mannheim (Indianapolis, IN, USA). Pyridine, trimethyl-
chiorosilane and hexamethyldisilazane were from Pierce (Rock-
ford, IL, USA). Acrylamide, bis-acrylamide, dextran sulfate, and
N,N,N',N'-tetramethylethylenediamine were from Biorad (Her-
cules, CA, USA) or Sigma. Dextran sulfate was from Oncor
(Gaithersburg, MD, USA). NTB-2 autoradiography emulsion,
developer (Kodak D-19), and fixative were from Eastman Kodak
Co. (Rochester, NY, USA). In vitro transcription was conducted
with the Riboprobe Gemini II Core System Kit from Promega
(Madison, WI, USA). 35S-UTP was from Amersham (Arlington
Heights, IL, USA). A cDNA probe for the f3-actin gene of the rat
was obtained from Ambion (Austin, TX, USA).
Animals
Male Sprague-Dawley rats, 8 to 9 weeks of age and weighing
275 to 300 g, were fed Harlan-Tekiad rat chow and water ad
libitum and housed on a 12 hours light/dark cycle (1800 to 0600).
Diabetes was induced by injecting streptozotocin (65 mg/kg)
intravenously. Blood glucose levels were determined 24 hours
after induction of diabetes using glucose oxidase reagent strips
read on an Accu-check reflectance meter, and only rats having a
blood glucose level greater than 300 mg/dl were considered to be
diabetic. Some rats were injected with 3-0-methylglucose (5.5
mmol/kg body wt) immediately prior to the streptozotocin infu-
sion to prevent the induction of diabetes and to serve as a control
for streptozotocin toxicity [22]. One set of diabetic rats was
treated with 2 and 5 units of NPH insulin at 0800 and 1700 hours,
respectively. A set of riondiabetic and diabetic rats was treated
dietetically with sorbiriil, an aldose reductase inhibitor, by thor-
oughly blending the desired amount of sorbinil (0.05% by weight)
with ground rat chow and 1% gum xanthan. This mixture was
pelleted and dried to constant weight [14].
Tissue myo-inositol and sorbitol
Rats were anesthetized with methoxyflurane and sacrificed by
exsanguination. The tissues of interest were removed, blotted,
weighed and boiled for 10 minutes in 3.0 ml of water containing
a-D-methylpyranoside as an internal standard and deproteinized
with 0.5 ml each of 0.19 M Ba(OH)2 and 0.19 M ZnSO4. After
centrifugation the supernatant was frozen and lyophilized. The
samples were then derivatized and the tissue content of rnyo-
inositol and sorbitol determined by gas chromatography as previ-
ously described [6, 211.
Cloning of the rat SMIT
The rat SMIT cDNA was cloned using reverse transcription and
the polymerase chain reaction (RT-PCR) as described previously
[23] with oligonucleotides homologous and complementary to
nucleotides 53 to 72 and 396 to 416 of the canine myo-inositol
transporter eDNA [7]. The sequences were 5'-TTTGAATTCCT-
GGTCATGTGCATTGGT-3' and 5 '-TT'TAAGCrrGGTGAA-
GATATAGAG-3', respectively. The 363 base pair amplified
fragment was subcloned into pGEM 3Zf(+), and the identity of
the eDNA was confirmed by double stranded sequencing of the
eDNA using an ABI automated DNA sequencer. Comparison of
the cloned rat sequence to the canine sequence demonstrated
90% homology at the nucleotide level.
RNA isolation and gel electrophoresis
Immediately upon removal from the animal, kidneys were
either snap-frozen in liquid nitrogen and stored at —70°C or
rapidly dissected into cortex, outer and inner medullary sections
and snap-frozen. RNA was prepared using the guanidine isothio-
cyanate-cesium chloride method [21]. RNA was quantitated by
measuring the absorbance at 260 nm, and the integrity of the
RNA and accuracy of quantitation were confirmed by size-
separating 7 jig of the RNA by denaturing gel electrophoresis
using 1.5% agarose [23] and visually comparing the intensity of
the 28S and 18S ribosomal RNA bands after ethidium bromide
staining.
Quantitation of SMIT mRNA levels
SMIT mRNA levels were quantitated using a solution hybrid-
ization/RNase protection assay as described previously [8, 23, 24].
[32P]-labeled antisense SMIT mRNAs were transcribed using SP6
RNA polymerase and the eDNA construct in pGEM 3Zf(+)
described above that had been linearized with Hindlil. Antisense
SMIT mRNAs were then incubated at 45°C in 75% formamide/
0.4 M NaCI with 20 jig of RNA. After 16 hours incubation, the
samples were digested with RNases A and T1 at 30°C for one
hour. This procedure resulted in the complete digestion of
unprotected RNA. The protected double stranded hybrids were
collected by ethanol precipitation and electrophoresed through an
8% polyacrylamide/8 M urea denaturing gel. To verify equal
loading and demonstrate the specificity of the effect of diabetes on
SMIT mRNA levels, /3-actin mRNA levels were determined
simultaneously. The amount of /3-actin in whole kidney or the
dissected regions was not significantly different from normal and
diabetic rats. /3-actin and SMIT mRNAs were represented as a
single band on the autoradiogram of the gel with the intensity of
the bands being proportional to the /3-actin and SMIT mRNA
levels in the sample. SMIT mRNA levels were quantitated by
scanning densitometry of the autoradiogram using a GS 300
transmitting/reflectance scanning densitometer (Hoefer, San
Francisco, CA, USA) interfaced with a model HP 3396A Hewlett-
Packard integrator (Avondale, PA, USA), and were normalized to
/3-actin levels. Since /3-actin mRNA levels were consistent nor-
malizing the SMIT mRNA values to j3-actin mRNA did not alter
the results.
Northern analysis
Twenty micrograms of RNA was size-separated by 1.0% dena-
turing gel electrophoresis and transferred to nitrocellulose by
diffusion transfer [25]. Transfer was confirmed by ethidium bro-
mide staining of the gel after transfer. The membrane was then
dried and RNA crosslinked using a UV Stratalinker 1800 (Strat-
agene, La Jolla, CA, USA). [32P]-labeled antisense RNAs, which
were prepared as described above, were used. Blots were prehy-
bridized for one hour at 42°C in 5 x SSPE (20 x SSPE is 5 M
NaCI; 22 mM EDTA; 230 mi NaH2PO4, pH 7.4), 2x Denhardt's
solution, 0.1% SDS and 100 jig/mI tRNA. The labeled probe (itt'
cpm) was then hybridized to the blot in the above hybridization
buffer at 42°C for 36 hours. The blot was then washed three times
for 15 minutes in 1 X SSPE/0.5% SDS at 22°C and for one hour
in 0.2 X SSPE!0.1% SDS at 60°C. The blot was then exposed to
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Kodak X-Omat film. The size of the SMIT gene product was
determined by comparison to RNA markers that were run
simultaneously on the gel.
In situ hybridization
Kidneys were prepared for in situ hybridization using both
paraffin-embedded and frozen sections. Kidneys to be paraffin-
embedded were prepared as follows. Adult Sprague-Dawley rats
were anesthetized with ketamine-HCI and perfused-fixed via the
left ventricle with freshly prepared 4% paraformaldehyde in
phosphate-buffered-saline (PBS), pH 7.4, at 37°C. Tissues were
removed, sliced, immersed in fixation solution for two hours at
4°C, and embedded in paraffin blocks. Tissues were sectioned to 5
sm thickness and mounted onto poly-L-lysine coated slides
(Fisher). Slides were air dried and stored with desiccant at room
temperature in an airtight box. When the sections were to be
prepared for hybridization, they were heated at 60°C overnight,
deparaffinized with xylene for one hour, then rehydrated in
graded ethanols.
Kidneys were prepared for frozen section using rats that were
anesthetized as described above. The kidneys were removed,
rapidly sliced to —2 mm thickness, and snap-frozen in liquid
isopentane. Tissues were sectioned on a cryostat to 7 sm thick-
ness and mounted onto poly-L-lysine coated slides. After airdry-
ing for a few minutes, sections were fixed at 4°C for 10 minutes.
Slides were then dehydrated by graded ethanols and stored with
desiccant at —20°C in an airtight box. Before hybridization,
cryosections were allowed to come to room temperature and then
heated at 50°C for five minutes.
35S-labeled SMIT antisense and sense RNAs were synthesized
from the rat SMIT eDNA as described above. The plasmid was
linearized with HindlII (for sense) or EcoRI (for antisense), and
35S-labeled probes were prepared using the Riboprobe Gemini II
Core System kit. The reaction mixture contained 11 avi 35UTP,
and either T7 (for sense) or SP( (for antisense) RNA polymerase
(2 U/pd). The incubation proceeded for 60 minutes at 37°C, after
which additional enzyme was added and the reaction allowed to
continue for another 60 minutes. DNase (1 U) was then added for
15 minutes at 37°C to degrade the template. The correct size of
the synthesized RNAs (363 nt) was confirmed by 1.5% agarose gel
electrophoresis and autoradiography. The probes were purified
from unincorporated nucleotide by a single phenol-chloroform
extraction and ethanol precipitation.
The prehybridization and hybridization steps were conducted
according to the general methods described [26]. Immediately
before hybridization, both paraffin and frozen sections were fixed
in freshly prepared 4% paraformaldehyde in PBS at 4°C for 10
minutes and rinsed with 2 X SSC (300 mrvt NaC1, 30 m Na
citrate). Sections were treated with 1 jsg/ml proteinase K in 100
mM Tris and 50 mrvi EDTA (pH 8) at 37°C for 40 minutes, rinsed
in PBS, and acetylated with 0.1 M triethanolamine and 0.25%
acetic anhydride at room temperature for 10 minutes. After
rinsing with 2 X SSC, sections were dehydrated in graded ethanols
and air dried.
The 35S-UTP labeled antisense RNAs were denatured at 80°C
for three minutes before being added to the hybridization solution
which contained lx Denhardt's solution, 50% deionized form-
amide, 0.3 M NaC1, 20 mrvi Tris, 5 mvi EDTA, 0.5 mg/mI yeast
tRNA, 80 jsg/ml denatured salmon sperm DNA, 10 m'vi
Na,HCO1, 10% dextran sulfate, and 0.1 M dithiothreitol, pH 8.0.
The final concentration of the antisense RNAs in the hybridiza-
tion solution was -—12,000 cpm/jsl. Approximately 50 pd of the
solution was spread over the sections, and the sections were
hybridized for 16 to 20 hours at 50°C in a humidified chamber.
Following hybridization, slides were rinsed in 4 X SSC containing
10 mM dithiothreitol at 50°C for 40 minutes. Sections were then
washed at high stringency (50% formamide, 2 x SSC, and 25 mM
dithiothreitol) at 60°C for 30 minutes, rinsed (4 M NaCl, 10 mrvi
Tris, 5 mi EDTA, and 25 mi dithiothreitol, pH 8), and treated
with 20 sg/ml RNase A and I U/pd RNase T1 for 30 minutes at
37°C. The tissues were rinsed again in a series of high stringency
washes terminating with 0.1 X SSC and 10 ms /3-mercaptoethanol
at 50°C for 15 minutes after which they were rinsed with 0.1 ><
SSC and dehydrated in graded ethanols containing 0.3 M ammo-
nium acetate. The sections were then coated with NTB-2 autora-
diography emulsion, diluted 1:1 in distilled H20, air dried, and
exposed for 4 to 13 weeks at 4°C before being developed. Sections
were counterstained with toluidine blue.
Data analysis
myo-Inositol and sorbitol content are presented as mean SE,
and the significance of differences was calculated by Student's
t-test. For analysis of SMIT mRNA levels, differences between
control and treated-group means were assessed for statistical
significance using the one-tailed multiple comparison procedure
of Dunnett.
Results
Changes in body weight and blood glucose levels
Data in Table 1 show the plasma glucose level and beginning
and ending body wts for each group of rats in the study. Blood
glucose level was increased threefold in the diabetic and sorbinil-
treated diabetic rats and both groups lost weight compared to
their age-matched controls. Treating diabetic rats with insulin
prevented the increase in blood glucose level and weight loss.
Pretreating rats with 3-0-methyiglucose prior to the injection of
streptozotocin prevented diabetes; weight gain by these rats was
normal.
SMIT mRNA levels
The effect of diabetes on renal SMIT mRNA levels as deter-
mined by Northern blot analysis is presented in Figure 1. Previ-
ously, Northern analysis of RNA from MDCK cells using a
full-length SMIT eDNA probe revealed numerous hybridizing
bands, with sizes ranging from 1.0 to 13.5 kb, with a major band
appearing at 10.5 kb [7]. Northern blot analysis using RNA from
whole kidneys isolated from normal and streptozotocin-induced
diabetic rats revealed a similar pattern of hybridizing bands.
However, diabetes caused a fourfold increase in the intensity of
the 10.5 kb band. To provide a more quantitative estimate of the
increase in SMIT mRNA content we conducted an RNase
protection assay. Figure 2 shows the SMIT mRNA levels and the
corresponding /3-actin mRNA levels (Fig. 2 A and B, respectively)
from eight randomly selected kidney samples from control and
diabetic rats. These data show that the increase in SMIT mRNA
levels in diabetic rat kidney was not accompanied by an increase
in /3-actin mRNA levels. As a further control, Figure 2C demon-
strates that the integrity and quantity of total RNA used in these
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Group Duration N
Begin weight End weight
Serum glucose mMg
Normal
3 day 4 278 7 300 6 11.7 0.5
7 day 4 293 7 318 26 10.8 1.0
28 day 4 302 12 388 25 11.9 1.0
42 day 9 285 6 414 9 17.1 1.4
180 day 3 271 4 573 9 14.9 2.5
Diabetic
3 day 12 283 7 243 13 37.4 47a
7 day 12 284 4 266 4 34.3 1.Oa
28 day 12 294 4 268 11 41.0 2.7k'
42 day
+ Insulin (42 day)
9
8
281 6
278 7
261 13
404 13"
44.3 3.3
9.8 3.1"
+Sorbinil (42 day) 9 279 17 262 17 41.8 3.2k'
180 dayc 3 257 6 375 3 40.5 1.4'
3-0-Methylglucose 3 274 4 302 3' 11.8 06h
On day 0, male Sprague-Dawley rats were injected with vehicle alone
(normal) or 65 mg/kg streptozotocin. Some of the rats were treated with
3-O-methylglucosc prior to injection of streptozotocin. Rats were then
maintained on a control diet or a diet supplemented with 0.05% sorbinil.
One set of rats was injected twice daily with NPH insulin. After the
designated number of days, rats were weighed and sacrificed, and serum
glucose was determined as described in the Methods section. 3-0-
Methylglucose-treated rats were sacrificed 7 days after injection of strep-
tozotocin. The data are expressed as the mean
P < 0.05 compared to normalhP < 0.05 compared to diabetic
These rats were treated with 50 mg/kg streptozotocin to ensure
long-term survival
studies were similar, as assessed by ethidium bromide staining of
the 18S and 28S rRNA.
The effect of the duration of diabetes on SMIT mRNA levels is
shown in Figure 3. Upon induction of diabetes, SMIT mRNA
levels in whole kidney increased 4.5-fold after three days of
diabetes and remained 2.5-fold greater than the level in control
animals after six weeks of diabetes. In a group of rats destined to
be diabetic for 24 weeks, we used a lower dose of streptozotocin
(50 mg/kg) to improve the probability of survival. These rats were
comparably hyperglycemic, but, unlike the rats which received 65
mg/kg streptozotocin, these rats gained weight during the 24
weeks period (Table 1). They also had a significantly increased
SMIT mRNA content, but the amount of SMIT mRNA was
significantly less than the three days diabetic rats. The increase in
SMIT mRNA levels in diabetic rat kidneys was not due to
streptozotocin toxicity. Treating rats with 3-0-methylgiucose prior
to the injection of streptozotocin, prevented the streptozotocin-
induced onset of diabetes and the increase in renal SMIT mRNA
levels.
We also asked if the increase in SMIT mRNA level might be
the result of the hyperglycemia or whether it might be dependent
on an increase in sorbitol. We therefore treated a group of
diabetic rats with insulin or sorbinil for six weeks. Treating
diabetic rats with insulin normalized blood glucose levels and
prevented the diabetes-induced increase in renal SMIT mRNA
levels (Fig. 4). Treating diabetic rats with sorbinil prevented the
characteristic increase in sorbitol levels in the lens and sciatic
nerve (data not shown). However, sorbinil treatment did not
18S 
Fig. 1. Northern blot analysis of SMIT mRNA levels in normal (C) and
diabetic (D) kidney. Twenty micrograms of total RNA was size-separated
in a 1.0% agarose gel, transferred to nitroeellulose and hybridized to a
32P-labeled SMIT eDNA as described in the Methods section.
prevent the diabetes-induced increase in renal SMIT mRNA
levels.
Analysis by region of the kidney
To gain a better understanding of the regional changes in renal
SMIT mRNA levels, we examined the relative abundance of
SMIT mRNA in the cortex, outer medulla, and inner medulla
regions of normal and diabetic kidneys (Fig. 5). In normal
kidneys, SMIT mRNA levels were greater in both outer medulla
and inner medulla than in cortex. Based on an arbitrary value of
unity for the normal cortex, the relative abundance (after normal-
ization using /3-actin mRNA levels) for cortex:outer medulla:inner
medulla was 1.0:3.4:7.0. In the comparable regions of kidneys
from rats made diabetic for seven days, the ratio was 1.0:6.3:5.5.
Thus, the general pattern of larger amounts of SMIT mRNA in
inner and outer medulla was true for both normal and diabetic
kidneys, but the pattern was altered in diabetes. Whereas the
abundance of SMIT mRNA in all regions at least tended to be
higher than normal, the amount in the outer medulla was
significantly increased. It appears that the major region contrib-
uting to the increase in SMIT mRNA levels induced by diabetes
in the whole kidney was the outer medulla.
The myo-inositol and sorbitol content of the cortex, outer
medulla, and inner medulla from normal and diabetic rats is
shown in Table 2. In normal rats sorbitol content was highest in
the inner medulla and was increased significantly in all regions by
diabetes. The myo-inositol content followed a pattern that was
similar to the order of SMIT mRNA abundance: cortex < outer
medulla < inner medulla. Following seven days of diabetes, the
myo-inositol content was significantly increased in the outer
medulla and unchanged in the cortex and inner medulla.
In Situ hybridization
Figures 6 and 7 show the localization of SMIT mRNA within
different regions of the kidney. We show the results from paraffin
sections because the morphology is superior; however, the frozen
sections showed qualitatively the same pattern with a lower
background. The signal increased from the superficial cortex to
the junction of the inner and outer medulla. On close examina-
tion, the only structure that could be identified as containing
SMIT mRNA was the thick ascending limb of Henle's loop. There
Table 1. Body weight and serum glucose levels in normal, diabetic,
diabetic treated with insulin, diabetic treated with sorbinil and
3-O-methylglucose-treated rats
2 3 4 5 6 7 8
-
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Fig. 2. Representative quantitation gel and
autoradiograms of normal and diabetic rat kidney.
Twenty micrograms of total RNA were used in an
RNase protection assay to simultaneously determine
SMIT (A) and -actin (B) mRNA levels as described
in the Methods section. Seven micrograms of the
same RNA was size-separated by agarose gel
electrophoresis, and 28S and 18S ribosomal bands
were visualized by ethidium bromide staining of the
gel (C). Lanes 1 and 2, normal; lanes 3 and 4, three
days diabetic; lanes 5 and 6, seven days diabetic;
lanes 7 and 8, 28 days diabetic.
Fig. 3. Levels of SMIT mRNA in whole kidney from normal or streptozo-
tocin-treated rats. 30MG (3-0-methylglucose) indicates pretreatment to
prevent diabetes. Values were determined by RNase protection assay at
the time indicated after streptozotoein injection. 3-0-methylglucosc
treated rats were studied seven days after injection. Data are expressed as
the mean from 9 or 12 rats, SE. 3-0-Mcthylglueose (N = 3). *P < 0.05
compared to normal; +P < 0.05 compared to 3-day diabetic.
Fig. 4. Levels of SMIT mRNA in whole kidney from normal rats, diabetic
rats, diabetic rats treated with sorbinil, and diabetic rats treated with insulin.
Measurements were made six weeks after streptozotocin injection by
RNase protection. Data are expressed as the mean from 9 rats, SE. *JJ <
0.05 compared to normal; +P < 0.05 compared to diabetic.
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was an abrupt change in signal at the border of the inner and outer
medulla, a fact that made it easy to identify the medullaiy thick
ascending limb. Cortical thick ascending limbs also showed some
signal, but it was less pronounced than that in the mcdullary thick
limbs. The use of toluidine blue in paraffin sections facilitated the
identification of the collecting ducts because intercalated cells are
brightly stained with this agent. Collecting ducts did not display a
significant signal in any region.
The signal in the inner medulla was not localized to any
particular structure, hut appeared to be diffuse. Within the inner
medulla, the signal intensity was greater at the tip of the papilla
than at the base (Fig. 7 A, B). This pattern was observed
consistently, and was more pronounced in sections displaying the
entire length of the papilla. The sense (control) probe did not
display such a pattern.
The signal from the diabetic kidneys was qualitatively similar to
normal kidneys. The only structures that could be clearly identi-
fied as having large amounts of SMIT mRNA were the cortical
and medullary thick ascending limbs of Henle's loop. However,
the pattern in the papilla was different. Whereas the normal
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Cortex Outer Inner
medulla medulla
Fig. 5. Levels of SMIT mRNA by kidney region. Data are expressed as the
mean from 9 rats, SE, with the level of SMIT mRNA in the cortex of
normal rats arbitrarily assigned a value of 1.0. All values factored for
-actin mRNA. Symbols are: () control; () diabetic; *P < 0.05
compared to control.
papilla showed an increase in signal close to the tip, this gradient
was less prominent or absent in papilla from diabetic rats (data
not shown).
Discussion
Our results show that the distribution of SMIT mRNA in the
normal rat kidney is similar to the content of myo-inositol; the
amount of each is highest in inner medulla and lowest in cortex.
There is general agreement that the higher level of myo-inositol in
the medulla, as an organic osmolyte, plays an important role in
defending the cell from the effects of hypertonicity [3, 27]. The
process by which myo-inositol accumulates in the medulla involves
an increase in Na-dependent myo-inositol uptake via SMIT.
Hypertonicity increases SMIT activity in cultured mesangial cells
and renal epithelial cells [28—301 as well as other cells [10, 31—33].
In addition, maneuvers that increase the tonicity of the medulla in
vivo, such as dehydration, can increase myo-inositol content [34].
Reducing medullary tonicity by water diuresis or by administering
loop diuretics causes a reduction in medullary myo-inositol con-
tent [35, 36]. Thus, there is good evidence to support the idea that
increases in extracellular tonicity cause an increase in Na-
dependent myo-inositol uptake, which in turn produces an in-
crease in intracellular #nyo-inositol content.
There is increasing evidence that an important part of the
increased capacity for myo-inositol uptake in response to hyper-
tonicity includes an increase in the level of SMIT mRNA.
Long-term (days) water deprivation produces an increase in
SMIT mRNA [34] and acute hypertonic NaC1 infusion increases
SMIT mRNA in the medulla within hours, an effect that is
blocked by furosemide [37]. These results are consistent with the
idea that hypertonicity enhances SMIT mRNA levels and may
regulate tissue myo-inositol content by regulating expression of
the SMIT protein. In vitro studies using cultured cells also support
this idea. Exposing cultured mammalian cells to hyperosmotic
medium causes a rapid increase in myo-inositol transport [10,
28—321 that is preceded by an increase in SMIT mRNA levels [8,
33]. In MDCK cells the osmotic induction of SMIT activity and
mRNA levels is due to an increase in transcription of the SMIT
Condition Region
Sorbitol myo-inositol
nmol/mg wet weight
Normal Cortex
Outer medulla
Inner medulla
0.02 0.02
0.03 0.03
3.2 0.6
4.4 0.2
9.9 2.2
28.3 4.3
Diabetic Cortex
Outer medulla
Inner medulla
0.19 0.02"
0.19 0.05
7.7 1.1"
4.5 0.4
16.3 2.9"
23.6 1.7
Normal and diabetic rats were sacrificed 7 days after induction of
diabetes and their kidneys were removed and dissected as described in the
Methods section. myo-lnositol and sorbitol content was determined by gas
chromatography. Data are expressed as the mean from 8 normal and 8
diabetic rats,
P < 0.05 compared to normal
gene [9]. At the present time the mechanism responsible for the
increase in SMIT gene transcription induced by hypertonicity in
the kidney is unknown.
The specific cells in the renal medulla that are responsible for
myo-inositol uptake in response to hypertonicity have only re-
cently been addressed. Recently, Yamauchi et al reported that
SMIT mRNA is predominantly present in the medullary thick
ascending limbs of Henle's loop [37]. They also identified SMIT
mRNA in cortical thick limb and macula densa cells [37]. Our
studies using in situ hybridization are generally consistent with
these results. We also found that the medullary thick ascending
limbs of Henle's loop displayed the greatest amount of SMIT
mRNA, and that the SMIT mRNA content in cortical thick
ascending limbs was less apparent then in the medullary thick
ascending limbs. In the inner medulla SMIT mRNA did not
appear to be localized to any specific cell type, but there was an
apparent gradient with SMIT mRNA levels increasing from the
outer/inner medullary border to the tip of the papilla. In contrast
to Yamauchi et al, we were not able to localize SMIT mRNA to
inner medullary collecting ducts [37].
The demonstration that SMIT mRNA is localized to the
medullary thick ascending limb of Henle's loop provides a plau-
sible explanation for the observation that myo-inositol contributes
to a relatively greater proportion of the osmolyte content of the
outer medulla than to the inner medulla [36, 38]. To the extent
that SMIT mRNA expression is related to the magnitude of
Na-dependent myo-inositol transport, myo-inositol content of
the thick ascending limbs would be relatively high. However, to
our knowledge the transport rates of Na '-dependent niyo-inositol
uptake has not been examined in specific nephron segments.
The intense SMIT mRNA signal in the medullary thick ascend-
ing limb demonstrated by in situ hybridization contrasts with the
relatively diffuse signal in the inner medulla. This contrast is
accentuated by the observation that the total amount of SMIT
mRNA, factored for total RNA or by -actin mRNA level, is
greater in the inner medulla than outer medulla. The reason that
SMIT mRNA appears more dramatic in the outer medulla than
inner medulla by in situ hybridization, and yet by RNase protec-
tion assay there is more SMIT mRNA in the inner medulla, may
he partly explained by its localization to a single segment in the
outer medulla. It is possible that the diffuse distribution of the
signal in the inner medulla creates only the illusion that there is
less SMIT mRNA than in the outer medulla. On the other hand,
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Fig. 6. In situ hybridization analysis of SMIT mRNA in normal kidney paraffin sections. Brightfleld (A, C, E) and darkfield (B, D, F) Sections of Cortex
(A and B, x200), outer medulla (C and D, x100), and inner/outer medullary junction (E and F, X100) are demonstrated. In the cortex, signal was
detected in cortical thick ascending limb of Henle's loop (cT). There was no apparent signal (above background) in glomcrulus (G), proximal tubule
(P), or cortical collecting duct. The signal was more intense in outer medulla, particularly in inner stripe. Note junction of inner (right) and outer stripe
(left) in C and D. There was no detectable signal (above background) in outer medullary collecting duct or thin limbs of Henle's loop. Signal abruptly
changes at the transition between thin ascending (lower) and thick ascending limb of Henle's ioop (upper) seen in E and F.
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Fig. 7. In situ hybridization analysis of SMITmRIVA in normal papilia (A and B, x100), junction of outer (upper) and inner (lower) medulla of kidney from
diabetic rat (C and D, x2OO), and sense probe in normal kidney from junction of outer (left) and inner (right) medulla (F and F, X100). The signal in papilla
was not confined to any particular structure but was increased close to the tip. Papilla from diabetic animals did not show this gradient. The signal in
the Outer medulla of the diabetic kidney was not qualitatively different from normal; no signal (above background) was detected in collecting duct (C).
Sense probe consistently gave a uniform background signal.
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there may be particular conditions in the inner medulla that
prevent full hybridization that is not present in the conditions
under which the RNase protection assay is performed.
Our observation that there is more myo-inositol in inner
medulla than outer medulla under normal conditions contrasts
with others who have reported similar amounts in each region or
even less myo-inositol in the inner medulla [11, 35, 36, 38]. The
reason for this difference is not clear. We note, however, that the
assay for myo-inositol in the other studies used HPLC or an
enzymatic assay while we used gas chromatography (GC). There
may be unrecognized interfering substances in the inner medulla
that confound the interpretation of absolute values obtained by
one or the other methods. We also note that, whereas the content
of myo-inositol in the inner medulla decreases toward the tip (as
measured by HPLC), the amount of SMIT mRNA evident by in
situ hybridization increases toward the tip (Fig. 7) [37]. Given that
hypertonicity causes an increase in SMIT mRNA and myo-inositol
transport, one would expect that the myo-inositol content would
be higher in the inner medulla and would increase toward the tip
of the papilla. The potential interaction of other materials in the
inner medulla with the detection of myo-inositol by either HPLC
or GC may need further evaluation. Nevertheless, the localization
of SMIT mRNA to the ascending thick limb of Henle's loop
provides an excellent explanation for the disproportionately large
levels of myo-inositol in the outer medulla.
In kidneys of diabetic rats SMIT mRNA is significantly in-
creased. The increase in SMIT mRNA was not due to streptozo-
tocin toxicity, and was prevented by insulin treatment. These
results suggest that hyperglycemia caused this effect. Analysis of
the regional distribution of SMIT mRNA revealed that diabetes
caused a significant increase in both SMIT mRNA and myo-
inositol content in the outer medulla without significantly effecting
the levels in the cortex or inner medulla. The distribution pattern
of SMIT mRNA in the outer medulla, determined by in situ
hybridization, was not altered by diabetes. The most straightfor-
ward interpretation of these data are that the increased SMIT
mRNA in cells of the ascending thick limb of Henle's loop
produces an increased capacity for myo-inositol uptake by these
cells, which in turn causes an enhanced myo-inositol content in the
outer medulla.
The changes in myo-inositol content and SMIT mRNA pro-
duced by diabetes are different than those produced by three days
of water deprivation. This model of dehydration increases SMIT
niRNA levels and myo-inositol content in both the outer and
inner medulla [34], whereas diabetes causes an increase in these
values only in the outer medulla. A possible explanation for these
diabetes-induced effects relates to the osmotic diuresis caused by
(1) a high plasma glucose concentration that exceeds the thresh-
old for proximal tubular resorption and (2) a consequent increase
in the fractional resorption of sodium by cells of the ascending
thick limb of Henle's loop in the diabetic kidney [39]. An increase
absorption of NaCI by the medullary ascending thick limb of
Henle's loop has also been proposed to explain the increase in
SMIT mRNA levels in the outer medulla that occurs following
hypertonic NaCl administration [37]. Why should an osmotic
diuresis produce an increase in SMIT mRNA in the medullary
ascending thick limb of Henle's loop? The simplest explanation
would be that the increased delivery of NaCI results in a greater
rate of NaCl absorption and a higher NaCI concentration in the
interstitium of the outer medulla. Although we are not aware of
specific measurements of sodium content of the outer medullary
interstitium in diabetic rats, there is good evidence to support this
idea in mannitol diuresis. It has long been known that an osmotic
diuresis produced by mannitol increases sodium concentration
(content) of the outer medulla [40]. It seems likely that most of
this increase is manifested in the peritubular interstitium. Thus,
these results support the idea that the NaCI concentration sur-
rounding the medullary ascending thick limb of Henle's loop plays
an important role in regulating the SMIT mRNA content of that
segment. This scenario is consistent with the recently reported
effect of basolateral hypertonicity on Na7myo-inositol cotrans-
port in cultured epithelial cells [41].
Diabetes did not alter the total SMIT mRNA content in the
inner medulla. However, in situ hybridization consistently showed
that the SMIT mRNA gradient that was observed in normal rats
was not apparent in the diabetic rats. The fact that there is a
higher SMIT mRNA content in the tip of the papilla of normal
rats is consistent with recently reported results [37]. The elimina-
tion of this axial gradient in diabetic rats parallels the effects of an
osmotic diuresis on the inner medullary axial sodium and urea
gradient where concentrations of these two solutes fall most
dramatically in the papillary tip [40]. We surmise that the changes
in medullary blood flow and alterations in fluid and solute delivery
within the inner medulla accompanying the osmotic diuresis are
responsible for the reduction in the axial SMIT mRNA gradient in
the papillary tip.
In summary, the concentration of SMIT mRNA in the ascend-
ing thick limb of Henle's loop accounts for the higher amount of
myo-inositol in the outer medulla compared to the other os-
molytes. Diabetes produces an increase in both the SMIT mRNA
and myo-inositol content in the outer medulla of the kidney. The
most likely mechanism responsible for increased SMIT mRNA
levels in the diabetic kidney is the peritubular hypertonicity
caused by hyperglycemia-induced osmotic diuresis and the in-
crease in sodium resorption.
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